SuperworthSI-BONE EPS SIBN
Diluted earnings per share by quarter and over the last twelve months, from 2017.
- Last 12 months, to Jun 30, 2026
- −$0.34
- Latest quarter, Q2 FY26
- −$0.09
- Fiscal year 2025
- −$0.44
SI-BONE's earnings per share was −$0.34 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.09.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.44 | n/a |
| FY2024 | −$0.76 | n/a |
| FY2023 | −$1.14 | n/a |
| FY2022 | −$1.79 | n/a |
| FY2021 | −$1.70 | n/a |
| FY2020 | −$1.52 | n/a |
| FY2019 | −$1.55 | n/a |
| FY2018 | −$3.59 | n/a |
| FY2017 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.09 | n/a | −$0.34 | |
| Q1 FY26 | −$0.10 | n/a | −$0.39 | |
| Q4 FY25 | −$0.04 | n/a | −$0.44 | |
| Q3 FY25 | −$0.11 | n/a | −$0.51 | |
| Q2 FY25 | −$0.14 | n/a | −$0.56 | |
| Q1 FY25 | −$0.15 | n/a | −$0.64 | |
| Q4 FY24 | −$0.11 | n/a | −$0.76 | |
| Q3 FY24 | −$0.16 | n/a | −$0.92 | |
| Q2 FY24 | −$0.22 | n/a | −$1.01 | |
| Q1 FY24 | −$0.27 | n/a | −$1.09 | |
| Q4 FY23 | −$0.27 | n/a | −$1.14 | |
| Q3 FY23 | −$0.25 | n/a | −$1.19 |
Against its peers
Companies in Medical - Instruments & Supplies nearest SI-BONE's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SIBNSI-BONE | −$0.34 | |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| MOVMovado | $1.80 | +137% a year |
| EYENational Vision | $0.61 | |
| MDXGMimedx | $0.04 | −81% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| Peer median | $0.94 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on SI-BONE
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.